{
    "clinical_study": {
        "@rank": "45253", 
        "arm_group": [
            {
                "arm_group_label": "Chronic Migraine Diagnosis", 
                "description": "This is a retrospective chart review for patients diagnosed with Chronic Migraine. There is no intervention in this study."
            }, 
            {
                "arm_group_label": "Other Headache Diagnoses", 
                "description": "This is a retrospective chart review of patients with headache diagnoses other than Chronic Migraine. There is no intervention in this study."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is a retrospective chart review in patients diagnosed with headache or migraine\n      to evaluate treatment patterns and diagnosis."
        }, 
        "brief_title": "A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Migraine Disorders", 
            "Headache"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Headache", 
                "Migraine Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of chronic migraine or other diagnosis of migraine or headache for a\n             minimum of 15 months\n\n          -  Eight (8) headache days per month for at least 1 of the preceding 15 months\n\n        Exclusion Criteria:\n\n          -  Not currently diagnosed with chronic migraine, headache or migraine\n\n          -  History of receiving botulinum toxin injections for the treatment of chronic\n             migraine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with a diagnosis of chronic migraine or other diagnosis of migraine or headache."
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946126", 
            "org_study_id": "GMA-BTX-CM-13-592"
        }, 
        "intervention": {
            "arm_group_label": [
                "Chronic Migraine Diagnosis", 
                "Other Headache Diagnoses"
            ], 
            "description": "There is no intervention in this study.", 
            "intervention_name": "No Intervention", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "overall_contact": {
            "email": "clinicaltrials@allergan.com", 
            "last_name": "Allergan Inc."
        }, 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Presence or Absence of Prophylactic Medication for Headache/Migraine", 
            "safety_issue": "No", 
            "time_frame": "15 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946126"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of Unique Prophylactic Medications Reported", 
                "safety_issue": "No", 
                "time_frame": "15 Months"
            }, 
            {
                "measure": "Frequency of Headache Days", 
                "safety_issue": "No", 
                "time_frame": "15 Months"
            }, 
            {
                "measure": "Frequency of Headache Days", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "measure": "Prophylactic Medications Used", 
                "safety_issue": "No", 
                "time_frame": "15 Months"
            }
        ], 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}